Vaccines List

V180 Dengue Vaccine

V180 is inactivated, containing only the truncated form of the structural envelope protein, which prevents serotypes from interfering with each other.Read more...

V591 SARS-CoV-2 Vaccine

V591 SARS-CoV-2 vaccine candidate uses a measles virus vector platform to deliver the antigens to the immune system to spur antibody production against SARS-CoV-2Read more...

Vaqta Hepatitis A Vaccine

Vaqta is an inactivated whole virus vaccine derived from hepatitis A virus grown in cell culture in human MRC-5 diploid fibroblasts. It contains inactivated virus of a strain which was originally derived by further serial passage of a proven attenuated strain.Read more...

Varivax Varicella Vaccine

Varivax is a live, attenuated varicella-zoster vaccine, a weakened form of the chickenpox virus.Read more...

Vaxart COVID-19 Oral Vaccine

Vaxart oral COVID-19 VXA-CoV2-1 is an oral tablet vaccine targeting both the spike protein (S) and nucleoprotein (N) of the novel SARS-CoV-2 coronavirus.Read more...

Vaxchora Cholera Vaccine

Vaxchora is a live attenuated recombinant oral V. cholerae O1 Inaba Vaccine Strain CVD 103-HgR, which is able to synthesize the immunogenic nontoxic B subunit of CT (encoded by the ctxB gene).Read more...

Vaxelis Hexavalent Vaccine

Vaxelis is a hexavalent (six-in-one) combination pediatric vaccine that includes antigens for diphtheria, tetanus, pertussis, and poliomyelitis from Sanofi and antigens for H. influenzae type b and hepatitis B from MerckRead more...

VAXNEUVANCE 15 Pneumococcal Vaccine

VAXNEUVANCE 15 Pneumococcal Vaccine (v114) consists of pneumococcal polysaccharides from 15 serotypes conjugated to a CRM197 carrier protein and includes serotypes 22F and 33F, which are commonly associated with the invasive pneumococcal disease worldwide.Read more...

Vaxzevria COVID-19 Vaccine (AstraZeneca)

Vaxzevria COVID-19 Vaccine (AstraZeneca) (AZD1222) (ChAdOx1 nCov-19) (C19VAZ) (CovidShield) consists of the replication-deficient simian adenovirus vector ChAdOx1, containing the genetic sequence of the SARS-CoV-2 Spike protein.Read more...

VBI-1501 Cytomegalovirus (CMV) Vaccine

VBI-1501 is a vaccine candidate containing a gB antigen which is a major antigen for the induction of neutralizing antibodies against CMV.Read more...

VBI-1901 Glioblastoma (GBM) Cancer Vaccine

VBI-1901 is a cancer vaccine that VBI Vaccines has designed to treat glioblastoma multiforme and medulloblastoma, two types of brain tumors.Read more...

VBI-2601 Hepatitis B Vaccine

VBI-2601 (BRII-179) is a hepatitis therapeutic vaccine candidate that targets B- and T-cell immunity through several key mechanisms of actionRead more...

VC2 HSV Vaccine

VC2 vaccine candidate is a live-attenuated, engineered version of HSV-1. The VC2 vaccine targets facial, ocular, and genital herpes caused by HSV-1 but may also protect against genital herpes caused by HSV-2. Read more...

Veklury (Remdesivir) Antiviral

Veklury (Remdesivir) is a nucleotide analog with broad-spectrum antiviral activity both in vitro and in vivo models against multiple emerging viral pathogens.Read more...

VGX-3100 HPV Cancer Vaccine

VGX-3100 is an investigational immunotherapy vaccine that includes DNA plasmids targeting the E6 and E7 proteins of HPV types 16 and 18.Read more...

Vidprevtyn COVID-19 Vaccine

The Sanofi - GSK Vidprevtyn protein-based vaccine candidate combines innovative technologies to produce an adjuvanted recombinant protein-based COVID-19 vaccine.Read more...

VIR-1111 HIV Vaccine

VIR-1111 HIV vaccine canidate is based on human cytomegalovirus that has been designed to elicit abundant T cells that recognize HIV epitopes in a way that differs from prior HIV vaccines.Read more...

Vitagerpavac Herpesvirus Vaccine

Vitagerpavac is a multivalent vaccine in the world for the treatment of chronic herpesvirus infection (HCV) of types I and IIRead more...

Vivotif Typhoid Vaccine

Vivotif Oral contains live bacteria called Salmonella typhi strain Ty21a, which do not cause typhoid fever.Read more...

VLA1601 Zika Vaccine

VLA1601 is a purified, inactivated, whole Zika virus vaccine candidate adsorbed on aluminum hydroxide (alum).Read more...

VLA2001 COVID-19 Vaccine

VLA2001 COVID-19 vaccine consists of inactivated whole virus particles of SARS-CoV-2 with high S-protein density, combined with two adjuvants, alum and CpG 1018.Read more...

VPM1002 Tuberculosis Vaccine

VPM1002  is a genetically modified BCG vaccine derived from the Mycobacterium bovis BCG subtype Prague characterized as rBCGÄureC::Hly+. Read more...

VRC5283 Zika Virus Vaccine

VRC5283 is a Zika Virus DNA Vaccine candidate.Read more...

VTP-500 MERS Vaccine

VTP-500 (ChAdOx1) MERS vaccine candidate treats MERS-CoV coronavirus utilizing the ChAdOx1 virus platform to encode MERS coronavirus spike protein in order to induce T cellsRead more...

VXA‑G1.1-NN Norovirus Vaccine

VXA-G1.1-NN is an Oral Vaccine Candidate Tablet addressing Norovirus.Read more...

Vyrologix (Leronlimab PRO 140) Antibody

Vyrologix (Leronlimab, PRO 140) is a drug candidate that is a CCR5 antagonist with the potential for multiple therapeutic indications including COVID-19 and HIVRead more...